Try our mobile app

Published: 2022-09-22 06:01:44 ET
<<<  go to ELLO company page
EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

Ellomay Capital Reports Results for the Three and Six Months Ended June 30, 2022
 
Tel-Aviv, Israel, September 22, 2022 – Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported unaudited financial results for the three month period ended June 30, 2022.
 
Financial Highlights
 

 •
Revenues were approximately €29.2 million for the six months ended June 30, 2022, compared to approximately €20.4 million for the six months ended June 30, 2021. This increase mainly results from the substantial increase in electricity prices in Spain.
 

 •
Operating expenses were approximately €13.1 million for the six months ended June 30, 2022, compared to approximately €7.6 million for the six months ended June 30, 2021. Depreciation expenses were approximately €8 million for the six months ended June 30, 2022, compared to approximately €7.1 million for the six months ended June 30, 2021. The increase in operating expenses mainly results from the introduction of the Spanish RDL 17/2021 that established the reduction, until June 30, 2022, of returns on the electricity generating activity of Spanish production facilities that do not emit greenhouse gases accomplished through payments of a portion of the revenues by the production facilities to the Spanish government. The increase in operating expenses also resulted from the Company’s biogas operations in the Netherlands that were impacted by the war in Ukraine causing shortages in certain raw materials and an increase in delivery prices. The increase in depreciation and amortization expenses is mainly attributable to the recognition of results of the Talasol PV Plant for the entire first half of 2022, compared to a partial recognition (commencing upon the achievement of PAC of the Talasol PV Plant on January 27, 2021) in 2021.
 

 •
Project development costs were approximately €1.6 million for the six months ended June 30, 2022, compared to approximately €1.1 million for the six months ended June 30, 2021. The increase in project development costs is mainly due to the advancing development of photovoltaic projects in Italy.
 

 •
General and administrative expenses were approximately €3.3 million for the six months ended June 30, 2022, compared to approximately €2.6 million for the six months ended June 30, 2021. The increase is mostly due to increased D&O liability insurance costs, increase in management fee paid pursuant to the new Management Services Agreement effective July 1, 2021, and an increase in salaries paid to employees.
 

 •
Share of losses of equity accounted investee, after elimination of intercompany transactions, was approximately €0.6 million for the six months ended June 30, 2022, compared to approximately €0.8 million for the six months ended June 30, 2021.
 

 •
Financing expenses, net was approximately €2.2 million for the six months ended June 30, 2022, compared to approximately €6.1 million for the six months ended June 30, 2021. The decrease in financing expenses, net, was mainly attributable to income resulting from exchange rate differences amounting to approximately €2.6 million in six months ended June 30, 2022, mainly in connection with the New Israeli Shekel (“NIS”) cash and cash equivalents and the Company’s NIS denominated debentures, compared to expenses in the amount of approximately €0.2 million for the six months ended June 30, 2021, caused by the 3.3% appreciation of the euro against the NIS during the six months ended June 30, 2022, compared to the 0.8% devaluation of the euro against the NIS during the six months ended June 30, 2021, income resulting from indexation to the increasing Israeli consumer price index (CPI)  and expenses recorded in 2021 amounting to approximately €0.8 million in connection with the early repayment of the Company’s Series B Debentures.
 

 •
Taxes on income were approximately €1.1 million for the six months ended June 30, 2022, compared to approximately €0.3 million for the six months ended June 30, 2021. The increase is mainly due to the substantial increase in electricity prices in Spain, resulting in higher taxable income of the Company’s Spanish subsidiaries.


•
Loss for the six months ended June 30, 2022 was approximately €0.6 million, compared to a loss of approximately €5.2 million for the six months ended June 30, 2021.
 

 •
Total other comprehensive loss was approximately €34.8 million for the six months ended June 30, 2022, compared to approximately €4.7 million for the six months ended June 30, 2021. The increase in total other comprehensive loss mainly resulted from changes in fair value of cash flow hedges, including a material reduction in the fair value of the financial power swap (the “Talasol PPA”) that covers approximately 80% of the output of the Talasol PV Plant. The Talasol PPA experienced a high volatility due to the substantial increase in electricity prices in Europe since the commencement of the military conflict between Russia and Ukraine. In accordance with hedge accounting standards, the changes in the Talasol PPA’s fair value are recorded in the Company’s shareholders’ equity through a hedging reserve and not through the accumulated deficit/retained earnings. The changes do not impact the Company’s consolidated net profit/loss or the Company’s consolidated cash flows. As the Company controls Talasol, the total impact of the changes in fair value of the Talasol PPA (including the minority share) is consolidated into the Company’s financial statements and total equity. Alongside the decrease in fair value of the Talasol PPA, the increase in the electricity prices is expected to have a positive impact on Talasol’s revenues from the sale of the capacity that is not subject to the Talasol PPA, resulting in an expected increase in Talasol’s net income and cash flows.


•
Total comprehensive loss was approximately €35.4 million for the six months ended June 30, 2022, compared to approximately €9.9 million for the six months ended June 30, 2021.
 

 •
The Company’s current liabilities as of June 30, 2022 include a liability in the amount of approximately €39 million in connection with current maturities of the Talasol PPA resulting from the decrease in the fair value of the Talasol PPA. The decrease in the fair value of the Talasol PPA does not impact the Company’s cash flow as Talasol’s revenues from the sale of electricity are expected to exceed its liability and payments to the Talasol PPA provider. Pursuant to the applicable accounting rules, the Company is required to recognize the fair value of expected future payments to the Talasol PPA provider as a liability but it does not recognize the expected revenues from the Talasol PV Plant as assets.
 

 •
EBITDA was approximately €10.6 million for the six months ended June 30, 2022, compared to approximately €8.4 million for the six months ended June 30, 2021. See the table on page 12 of this press release for a reconciliation of these numbers to profit and loss.
 

 •
Net cash provided by operating activities was approximately €8 million for the six months ended June 30, 2022, compared to approximately €7.3 million for the six months ended June 30, 2021. The net cash provided by operating activities for the six months ended June 30, 2022, included a nonrecurring advance payment of income tax as per a tax assessment agreement (timing differences of payable income tax) to the Israeli Tax Authority in connection with the Talmei Yosef PV Plant in the amount of approximately €3.2 million.
 

 •
As required under an amendment to IAS 16, “Property, Plant and Equipment” (the “Amendment”), the Company retrospectively applied the Amendment and revised the financial results as of and for the year ended December 31, 2021, and for the six months ended June 30, 2021. The Amendment required the Company to recognize the results of the Talasol PV Plant commencing connection to the grid (December 2020) instead of recognizing results commencing achievement of PAC (Preliminary Acceptance Certificate), which occurred on January 27, 2021. The revisions mainly included recognizing an increase in the balance of fixed assets against a corresponding increase in retained earnings and deferred tax as of December 31, 2021, and an increase in revenues and expenses, with a corresponding decrease in tax benefit and in the net loss for the six months ended June 30, 2021 and the year ended December 31, 2021.
 
CEO Review Second Quarter 2022
 
In the first half and the second quarter of 2022, the Company met the goals it set for itself. Compared to the corresponding period last year, the Company recorded an increase of approximately 43% in its revenues, which were higher than the projected revenues for the period. The cash flow from operations for the first half of 2022 was approximately €8 million, after deduction of a non-recurring advance payment of income tax as per a tax assessment agreement (timing differences of payable income tax) to the Israeli Tax Authority in connection with the Talmei Yosef PV Plant in the amount of approximately €3.2 million.

The profit for the second quarter of 2022 almost doubled compared to the corresponding period last year, and the net profit for the quarter was approximately €2.8 million, compared to a loss of approximately €2.5 million in the corresponding quarter last year.
 
Based on the preliminary results of the third quarter of 2022 currently available to the Company, it is expected that the Company will meet the goals it set for itself for the first nine months of 2022.
 

The Company operates on two main levels: the development of a backlog of projects in the PV field in Italy, Spain and Israel, and the construction and operation of projects. Currently, a pumped hydro storage project in the Manara Cliff in Israel, which is a mega project in scope, is under construction. In addition, 20 MV PV plants are also under advanced construction in Italy.
 
Activity in Spain: The Ellomay Solar project (28 MW PV) was connected to the electricity grid towards the end of the second quarter of 2022, therefore its effect on the quarter was negligible. During the third quarter of 2022 this PV plant operated at full capacity and the expected revenues from it for the third quarter of 2022 are approximately €2.5-3 million. The Talasol PV plant (300 MW PV), 51% held by the Company, met all expectations and in the first half of 2022 generated revenues in the amount of approximately €20.4 million.
 
Activity in Italy: The Company has approximately 600 MW PV projects under advanced development stages, of which licenses have been obtained for approximately 200 MW. Of these 200 MW PV projects, 20 MW are under advanced construction and the remainder (approximately 180 MW) are awaiting the results of a contractor tender which is expected to be finalized at the end of September 2022. The construction agreements are expected to be signed following the decision with respect to the contractor, and construction work will commence thereafter.
 
The Company has additional projects in earlier development stages and the intention is to reach a portfolio of approximately 1,000 MW PV in various degrees of development and operations by the year 2025.
 
The Company is negotiating a financing agreement for the financing of 600 MW PV projects that are in advanced development stages with a leading European bank in the field.
 
Activity in Israel: The Company is engaged in the construction and management of the Manara Cliff pumped storage project, which is in advanced construction.
 
The development of the licenses for the construction of 40 MW PV + 80 MW/hour storage in batteries is in advanced stages. A connection to the electricity grid was guaranteed for a large part of the project, the tender for contractors was concluded and a winning contractor was selected. The Company is in negotiations with financing entities for the purpose of obtaining financing for the project.
 
The Company continues to develop a portfolio of land for future projects in the field of PV and battery storage, including the potential expansion of the Talmei Yosef project.
 
Activity in the Netherlands: In connection with the war in Ukraine and the stoppage of Russian gas supply to Europe, there are substantial changes in the field of biogas in the Netherlands and Europe. Europe in general and the Netherlands specifically have set ambitious goals for increasing gas production from waste. Various incentives are being considered, the main of which is pushing the price of the green certificates upwards and as of today the price of the aforementioned certificates has increased from 13–15-euro cents per certificate to around 45-euro cents per certificate. The gas price for 2023, which is determined on the basis of the 2022 average, is also expected to be above 90-euro cents per cubic meter, a price that is higher than the cap of the subsidy (75-euro cents per cubic meter). Therefore, in 2023 and possibly also in 2024 the Company will examine the possibility of temporarily exiting the subsidy regime. Not using the subsidy during 2023 and 2024 will enable the Company to postpone the termination of the subsidy period (originally 12 years) by two years.
 
Green certificates are issued according to the amount of green gas supplied by the Company’s plants, whereby for every cubic meter supplied, the Company receives one green certificate. The Company currently expects to produce approximately 14 million cubic meters of green gas during 2023, which are expected to be sold at an average price of 45 Eurocents per certificate. The expected income to the Company is therefore approximately €6 million for 2023, compared to an average income from the sale of green certificates of approximately €2 million in previous years.
 
On the other hand, due to the war in Ukraine, there was an increase in the price of feedstock, which is based on agricultural residues, and in the cost of transportation and the price of electricity (which increased tenfold). These circumstances caused an increase in expenses, however the Company expects that the increase in income will exceed the increase in expenses. The increase in income is already partially reflected in the high prices of the green certificates and is expected to continue to be reflected next year as prices of green certificates are expected to continue to increase, and in addition gas prices are also expected to be high.
 
The increase in electricity prices in the Netherlands did not substantially affect 2 of the 3 biogas facilities owned by the Company, which produce the electricity and heat they consume for themselves. However, the Gelderland project, which was acquired in December 2020, is not equipped with the means to self-generate electricity and heat and is required to pay for the electricity, and therefore was negatively affected by the increase in the price of electricity. In May 2022, the Company received notification of approval for a subsidy for generation of electricity and heat in Gelderland and, in August 2022, a generator (CHP) was ordered and is expected to start producing electricity for the Gelderland facility this December or January.
 
The Company estimates that with the increasing importance of the biogas field, this field will enter a new period which is expected to substantially improve the results of the Company’s biogas facilities.

Use of NON-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company’s operating performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company’s commitments, including capital expenditures and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measure presented by other companies. The Company’s EBITDA may not be indicative of the Company’s historic operating results; nor is it meant to be predictive of potential future results. The Company uses this measure internally as performance measure and believes that when this measure is combined with IFRS measure it add useful information concerning the Company’s operating performance. A reconciliation between results on an IFRS and non-IFRS basis is provided on page 12 of this press release.

About Ellomay Capital Ltd.
 
Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol “ELLO”. Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.
 
To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:
 

 •
Approximately 35.9 MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;

•
9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel’s largest private power plants with production capacity of approximately 860MW, representing about 6%-8% of Israel’s total current electricity consumption;

•
51% of Talasol, which owns a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;

•
Groen Gas Goor B.V., Groen Gas Oude-Tonge B.V. and Groen Gas Gelderland B.V., project companies operating anaerobic digestion plants in the Netherlands, with a green gas production capacity of approximately 3 million, 3.8 million and 9.5 million (with a license to produce 7.5 million) Nm3 per year, respectively;

•
83.333% of Ellomay Pumped Storage (2014) Ltd., which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
 
For more information about Ellomay, visit http://www.ellomay.com.
 
Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company’s management. All statements, other than statements of historical facts, included in this press release regarding the Company’s plans and objectives, expectations and assumptions of management are forward-looking statements. The use of certain words, including the words “estimate,” “project,” “intend,” “expect,” “believe” and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company’s forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company’s forward-looking statements, including the impact of continued war between Russia and Ukraine, including its impact on electricity prices, availability of raw materials and disruptions in supply changes, the impact of the Covid-19 pandemic on the Company’s operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, changes in the market price of electricity and in demand, regulatory changes, including extension of current or approval of new rules and regulations increasing the operating expenses of manufacturers of renewable energy in Spain, increases in interest rates and inflation, changes in the supply and prices of resources required for the operation of the Company’s facilities (such as waste and natural gas) and in the price of oil, and technical and other disruptions in the operations or construction of the power plants owned by the Company. These and other risks and uncertainties associated with the Company’s business are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Kalia Rubenbach (Weintraub)
CFO
Tel: +972 (3) 797-1111
Email: hilai@ellomay.com
Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Financial Position

   
June 30,
    
December 31,
    
June 30,
  
   
2022
    
2021
    
2022
  
   
(Unaudited)
    
(Audited)
    
(Unaudited)
  
   
€ in thousands
    
Convenience Translation into US$ in thousands*
  
Assets
                  
Current assets:
                  
Cash and cash equivalents
    
59,951
      
41,229
      
62,287
  
Marketable securities
    
1,761
      
1,946
      
1,830
  
Short term deposits
    
-
      
28,410
      
-
  
Restricted cash
    
4,280
      
1,000
      
4,447
  
Receivable from concession project
    
1,786
      
1,784
      
1,856
  
Trade and other receivables
    
10,744
      
9,487
      
11,163
  
     
78,522
      
83,856
      
81,583
  
Non-current assets
                        
Investment in equity accounted investee
    
32,410
      
34,029
      
33,673
  
Advances on account of investments
    
1,554
      
1,554
      
1,615
  
Receivable from concession project
    
25,991
      
26,909
      
27,004
  
Fixed assets
    
352,680
      
340,897
      
366,424
  
Right-of-use asset
    
23,360
      
23,367
      
24,270
  
Intangible asset
    
4,418
      
4,762
      
4,590
  
Restricted cash and deposits
    
20,379
      
15,630
      
21,174
  
Deferred tax
    
23,723
      
12,952
      
24,648
  
Long term receivables
    
8,581
      
5,388
      
8,915
  
Derivatives
    
2,718
      
2,635
      
2,824
  
     
495,814
      
468,123
      
515,137
  
Total assets
    
574,336
      
551,979
      
596,720
  
                         
Liabilities and Equity
                        
Current liabilities
                        
Current maturities of long-term bank loans
    
12,306
      
126,180
      
12,786
  
Current maturities of long-term loans
    
10,000
      
16,401
      
10,390
  
Current maturities of debentures
    
19,785
      
19,806
      
20,556
  
Trade payables
    
2,059
      
2,904
      
2,138
  
Other payables
    
20,120
      
20,806
      
20,904
  
Current maturities of derivatives
    
38,996
      
14,783
      
40,516
  
Current maturities of lease liabilities
    
675
      
4,329
      
701
  
     
103,941
      
205,209
      
107,991
  
Non-current liabilities
                        
Long-term lease liabilities
    
16,206
      
15,800
      
16,838
  
Long-term loans
    
217,845
      
39,093
      
226,335
  
Other long-term bank loans
    
25,754
      
37,221
      
26,758
  
Debentures
    
93,973
      
117,493
      
97,635
  
Deferred tax
    
6,409
      
9,044
      
6,659
  
Other long-term liabilities
    
3,324
      
3,905
      
3,454
  
Derivatives
    
24,198
      
10,107
      
25,141
  
     
387,709
      
232,663
      
402,820
  
Total liabilities
    
491,650
      
437,872
      
510,811
  
Equity
                        
Share capital
    
25,605
      
25,605
      
26,603
  
Share premium
    
85,943
      
85,883
      
89,292
  
Treasury shares
    
(1,736
)
    
(1,736
)
    
(1,804
)
Transaction reserve with non-controlling Interests
    
5,697
      
5,697
      
5,919
  
Reserves
    
(11,763
)
    
7,288
      
(12,221
)
Accumulated deficit
    
(8,121
)
    
(6,899
)
    
(8,437
)
Total equity attributed to shareholders of the Company
    
95,625
      
115,838
      
99,352
  
Non-Controlling Interest
    
(12,939
)
    
(1,731
)
    
(13,443
)
Total equity
    
82,686
      
114,107
      
85,909
  
Total liabilities and equity
    
574,336
      
551,979
      
596,720
  

* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039)

Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Profit or Loss and Other Comprehensive Income or Loss

                         
   
For the Three months
ended June 30,
    
For the Six months
ended June 30,
    
For the year ended December 31,
    
For the six months ended June 30,
  
   
2022
    
2021
    
2022
    
2021
    
2021
    
2022
  
   
Unaudited
    
Unaudited
    
Audited
    
Unaudited
  
   
€ in thousands
    
€ in thousands
    
€ in thousands
    
Convenience Translation into US$ in thousands*
  
Revenues
    
17,435
      
13,193
      
29,196
      
20,393
      
45,721
      
30,334
  
Operating expenses
    
(7,161
)
    
(4,355
)
    
(13,132
)
    
(7,572
)
    
(17,590
)
    
(13,644
)
Depreciation and amortization expenses
    
(3,964
)
    
(4,025
)
    
(7,978
)
    
(7,076
)
    
(15,116
)
    
(8,289
)
Gross profit
    
6,310
      
4,813
      
8,086
      
5,745
      
13,015
      
8,401
  
                                                 
Project development costs
    
(843
)
    
(614
)
    
(1,554
)
    
(1,119
)
    
(2,508
)
    
(1,615
)
General and administrative expenses
    
(1,820
)
    
(1,309
)
    
(3,297
)
    
(2,572
)
    
(5,661
)
    
(3,425
)
Share of profits of equity accounted investee
    
(833
)
    
(1,389
)
    
(602
)
    
(772
)
    
117
      
(625
)
Operating profit
    
2,814
      
1,501
      
2,633
      
1,282
      
4,963
      
2,736
  
                                                 
Financing income
    
3,630
      
850
      
4,439
      
1,716
      
2,931
      
4,612
  
Financing income (expenses) in connection with derivatives and warrants, net
    
372
      
15
      
338
      
(109
)
    
(841
)
    
351
  
Financing expenses in connection with projects finance
    
(2,524
)
    
(2,193
)
    
(3,889
)
    
(3,658
)
    
(17,800
)
    
(4,041
)
Financing expenses in connection with debentures
    
(314
)
    
(788
)
    
(1,343
)
    
(2,764
)
    
(3,220
)
    
(1,395
)
Interest expenses on minority shareholder loan
    
(349
)
    
(557
)
    
(892
)
    
(939
)
    
(2,055
)
    
(927
)
Other financing expenses
    
(50
)
    
(699
)
    
(834
)
    
(384
)
    
(5,899
)
    
(867
)
Financing income (expenses), net
    
765
      
(3,372
)
    
(2,181
)
    
(6,138
)
    
(26,884
)
    
(2,267
)
                                                 
Profit (loss) before taxes on income
    
3,579
      
(1,871
)
    
452
      
(4,856
)
    
(21,921
)
    
469
  
Tax benefit (Taxes on income)
    
(808
)
    
(625
)
    
(1,087
)
    
(306
)
    
2,281
      
(1,129
)
Profit (loss) for the period
    
2,771
      
(2,496
)
    
(635
)
    
(5,162
)
    
(19,640
)
    
(660
)
Profit (loss) attributable to:
                                                
Owners of the Company
    
1,712
      
(3,183
)
    
(1,222
)
    
(5,252
)
    
(15,090
)
    
(1,270
)
Non-controlling interests
    
1,059
      
687
      
587
      
90
      
(4,550
)
    
610
  
Profit (loss) for the period
    
2,771
      
(2,496
)
    
(635
)
    
(5,162
)
    
(19,640
)
    
(660
)
Other comprehensive income (loss) item
                                                
that after initial recognition in comprehensive income (loss) were or will be transferred to profit or loss:
                                                
Foreign currency translation differences for foreign operations
    
(3,585
)
    
1,122
      
(3,683
)
    
1,684
      
12,284
      
(3,826
)
Effective portion of change in fair value of cash flow hedges
    
8,844
      
(3,273
)
    
(31,942
)
    
(5,202
)
    
(13,429
)
    
(33,186
)
Net change in fair value of cash flow hedges transferred to profit or loss
    
794
      
(221
)
    
821
      
(1,225
)
    
(3,353
)
    
853
  
Total other comprehensive income (loss)
    
6,053
      
(2,372
)
    
(34,804
)
    
(4,743
)
    
(4,498
)
    
(36,159
)
                                                 
Total other comprehensive income (loss) attributable to:
                                                
Owners of the Company
    
1,618
      
(652
)
    
(19,051
)
    
(1,764
)
    
3,124
      
(19,793
)
Non-controlling interests
    
4,435
      
(1,720
)
    
(15,753
)
    
(2,979
)
    
(7,622
)
    
(16,366
)
Total other comprehensive income (loss) for the period
    
6,053
      
(2,372
)
    
(34,804
)
    
(4,743
)
    
(4,498
)
    
(36,159
)
Total comprehensive income (loss) for the period
    
8,824
      
(4,868
)
    
(35,439
)
    
(9,905
)
    
(24,138
)
    
(36,819
)
                                                 
Total comprehensive income (loss) attributable to:
                                                
Owners of the Company
    
3,330
      
(3,835
)
    
(20,273
)
    
(7,016
)
    
(11,966
)
    
(21,063
)
Non-controlling interests
    
5,494
      
(1,033
)
    
(15,166
)
    
(2,889
)
    
(12,172
)
    
(15,756
)
Total comprehensive income (loss) for the period
    
8,824
      
(4,868
)
    
(35,439
)
    
(9,905
)
    
(24,138
)
    
(36,819
)
                                                 
Basic net earnings (loss) per share
    
0.13
      
(0.25
)
    
(0.10
)
    
(0.41
)
    
(1.18
)
    
(0.10
)
Diluted net earnings (loss) per share
    
0.13
      
(0.25
)
    
(0.10
)
    
(0.41
)
    
(1.18
)
    
(0.10
)


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Statements of Changes in Equity

                     
Non- controlling
    

Total
  
               
Attributable to shareholders of the Company
    
Interests
    
Equity
  
   
Share capital
    
Share premium
    
Accumulated Deficit
    
Treasury shares
    
Translation reserve from
foreign operations
    
Hedging Reserve
    
Interests Transaction reserve with
non-controlling Interests
    
Total
              
   
€ in thousands
  
For the six months ended
                                                            
June 30, 2022 (Unaudited):
                                                            
Balance as at January 1, 2022
    
25,605
      
85,883
      
(6,899
)
    
(1,736
)
    
15,365
      
(8,077
)
    
5,697
      
115,838
      
(1,731
)
    
114,107
  
Profit (loss) for the period
    
-
      
-
      
(1,222
)
    
-
      
-
      
-
      
-
      
(1,222
)
    
587
      
(635
)
Other comprehensive loss for the period
    
-
      
-
      
-
      
-
      
(3,466
)
    
(15,585
)
    
-
      
(19,051
)
    
(15,753
)
    
(34,804
)
Total comprehensive loss for the period
    
-
      
-
      
(1,222
)
    
-
      
(3,466
)
    
(15,585
)
    
-
      
(20,273
)
    
(15,166
)
    
(35,439
)
Transactions with owners of the Company, recognized directly in equity:
                                                                                
Issuance of Capital note to non-controlling interest
    
-
      
-
      
-
      
-
      
-
      
-
      
-
      
-
      
3,958
      
3,958
  
Share-based payments
    
-
      
60
      
-
      
-
      
-
      
-
      
-
      
60
      
-
      
60
  
Balance as at June 30, 2022
    
25,605
      
85,943
      
(8,121
)
    
(1,736
)
    
11,899
      
(23,662
)
    
5,697
      
95,625
      
(12,939
)
    
82,686
  
                                                                                 
For the six months ended
                                                                                
June 30, 2021 (Unaudited):
                                                                                
Balance as at January 1, 2021
    
25,102
      
82,401
      
8,191
      
(1,736
)
    
3,823
      
341
      
6,106
      
124,228
      
798
      
125,026
  
Profit (loss) for the period
    
-
      
-
      
(5,252
)
    
-
      
-
      
-
      
-
      
(5,252
)
    
90
      
(5,162
)
Other comprehensive income (loss) for the period
    
-
      
-
      
-
      
-
      
1,636
      
(3,400
)
    
-
      
(1,764
)
    
(2,979
)
    
(4,743
)
Total comprehensive income (loss) for the period
    
-
      
-
      
(5,252
)
    
-
      
1,636
      
(3,400
)
    
-
      
(7,016
)
    
(2,889
)
    
(9,905
)
Transactions with owners of the Company, recognized directly in equity:
                                                                                
Issuance of Capital note to non-controlling interest
    
-
      
-
      
-
      
-
      
-
      
-
      
-
      
-
      
8,682
      
8,682
  
Acquisition of shares in subsidiaries from non-controlling interests
    
-
      
-
      
-
      
-
      
-
      
-
      
(961
)
    
(961
)
    
961
      
-
  
Warrants exercise
    
454
      
3,348
      
-
      
-
      
-
      
-
      
-
      
3,802
      
-
      
3,802
  
Options exercise
    
22
      
-
      
-
      
-
      
-
      
-
      
-
      
22
      
-
      
22
  
Share-based payments
    
-
      
13
      
-
      
-
      
-
      
-
      
-
      
13
      
-
      
13
  
Balance as at June 30, 2021
    
25,578
      
85,762
      
2,939
      
(1,736
)
    
5,459
      
(3,059
)
    
5,145
      
120,088
      
7,552
      
127,640
  


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Changes in Equity (cont’d)

                     
Non- controlling
    

Total
  
               
Attributable to shareholders of the Company
    
Interests
    
Equity
  
   
Share capital
    
Share premium
    
Accumulated Deficit
    
Treasury shares
    
Translation reserve from
foreign operations
    
Hedging Reserve
    
Interests Transaction reserve with
non-controlling Interests
    
Total
              
   
€ in thousands
  
For the year ended
                                                            
December 31, 2021 (Audited):
                                                            
Balance as at January 1, 2021
    
25,102
      
82,401
      
8,191
      
(1,736
)
    
3,823
      
341
      
6,106
      
124,228
      
798
      
125,026
  
Profit (loss) for the year
    
-
      
-
      
(15,090
)
    
-
      
-
      
-
      
-
      
(15,090
)
    
(4,550
)
    
(19,640
)
Other comprehensive income (loss) for the year
    
-
      
-
      
-
      
-
      
11,542
      
(8,418
)
    
-
      
3,124
      
(7,622
)
    
(4,498
)
Total comprehensive income (loss) for the year
    
-
      
-
      
(15,090
)
    
-
      
11,542
      
(8,418
)
    
-
      
(11,966
)
    
(12,172
)
    
(24,138
)
Transactions with owners of the Company, recognized directly in equity:
                                                                                
Issuance of Capital note to non-controlling interest
    
-
      
-
      
-
      
-
      
-
      
-
      
-
      
-
      
8,682
      
8,682
  
Acquisition of shares in subsidiaries from non-controlling interests
    
-
      
-
      
-
      
-
      
-
      
-
      
(409
)
    
(409
)
    
961
      
552
  
Warrants exercise
    
454
      
3,419
      
-
      
-
      
-
      
-
      
-
      
3,873
      
-
      
3,873
  
Options exercise
    
49
      
-
      
-
      
-
      
-
      
-
      
-
      
49
      
-
      
49
  
Share-based payments
    
-
      
63
      
-
      
-
      
-
      
-
      
-
      
63
      
-
      
63
  
Balance as at December 31, 2021
    
25,605
      
85,883
      
(6,899
)
    
(1,736
)
    
15,365
      
(8,077
)
    
5,697
      
115,838
      
(1,731
)
    
114,107
  


Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Changes in Equity (cont’d)

                     
Non- controlling
    

Total
  
               
Attributable to shareholders of the Company
    
Interests
    
Equity
  
   
Share capital
    
Share premium
    
Retained earnings
    
Treasury shares
    
Translation reserve from
foreign operations
    
Hedging Reserve
    
Interests Transaction reserve with
non-controlling Interests
    
Total
              
   
Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039)
  
For the six month ended June 30, 2022 (unaudited):
                                                            
Balance as at January 1, 2022
    
26,603
      
89,230
      
(7,167
)
    
(1,804
)
    
15,964
      
(8,392
)
    
5,919
      
120,353
      
(1,799
)
    
118,554
  
Profit (loss) for the period
    
-
      
-
      
(1,270
)
    
-
      
-
      
-
      
-
      
(1,270
)
    
610
      
(660
)
Other comprehensive loss for the period
    
-
      
-
      
-
      
-
      
(3,601
)
    
(16,192
)
    
-
      
(19,793
)
    
(16,366
)
    
(36,159
)
Total comprehensive loss for the period
    
-
      
-
      
(1,270
)
    
-
      
(3,601
)
    
(16,192
)
    
-
      
(21,063
)
    
(15,756
)
    
(36,819
)
Transactions with owners of the Company, recognized directly in equity:
                                                                                
Issuance of Capital note to non-controlling interest
    
-
      
-
      
-
      
-
      
-
      
-
      
-
      
-
      
4,112
      
4,112
  
Share-based payments
    
-
      
62
      
-
      
-
      
-
      
-
      
-
      
62
      
-
      
62
  
 Balance as at June 30, 2022
    
26,603
      
89,292
      
(8,437
)
    
(1,804
)
    
12,363
      
(24,584
)
    
5,919
      
99,352
      
(13,443
)
    
85,909
  



Ellomay Capital Ltd. and its Subsidiaries
Condensed Consolidated Interim Statements of Cash Flow

   
For the three months
ended June 30,
    
For the six months
ended June 30,
    
For the year ended December 31,
    
For the six months ended June 30
  
   
2022
    
2021
    
2022
    
2021
    
2021
    
2022
  
   
Unaudited
    
Unaudited
    
Audited
    
Unaudited
  
   
€ in thousands
    
Convenience
Translation into US$*
  
Cash flows from operating activities
                                    
Loss for the period
    
2,771
      
(2,496
)
    
(635
)
    
(5,162
)
    
(19,640
)
    
(660
)
Adjustments for:
                                                
Financing expenses, net
    
(765
)
    
3,372
      
2,181
      
6,138
      
26,884
      
2,267
  
Profit from settlement of derivatives contract
    
-
      
-
      
-
      
(407
)
    
(407
)
    
-
  
Depreciation and amortization
    
3,964
      
4,025
      
7,978
      
7,076
      
15,116
      
8,289
  
Share-based payment transactions
    
60
      
6
      
60
      
13
      
63
      
62
  
Share of losses (profits) of equity accounted investees
    
833
      
1,389
      
602
      
772
      
(117
)
    
625
  
Payment of interest on loan by an equity accounted investee
    
-
      
859
      
-
      
859
      
859
      
-
  
Change in trade receivables and other receivables
    
235
      
(942
)
    
(2,579
)
    
(2,124
)
    
(1,883
)
    
(2,680
)
Change in other assets
    
(1,788
)
    
(812
)
    
53
      
(782
)
    
(545
)
    
55
  
Change in receivables from concessions project
    
(802
)
    
536
      
(550
)
    
757
      
1,580
      
(571
)
Change in trade payables
    
(726
)
    
(559
)
    
(801
)
    
(941
)
    
154
      
(832
)
Change in other payables
    
2,604
      
2,119
      
7,878
      
3,715
      
2,380
      
8,185
  
Income tax expense (tax benefit)
    
808
      
625
      
1,087
      
306
      
(2,281
)
    
1,129
  
Income taxes paid
    
(3,255
)
    
(15
)
    
(3,255
)
    
(15
)
    
(94
)
    
(3,382
)
Interest received
    
451
      
494
      
922
      
921
      
1,844
      
958
  
Interest paid
    
(4,520
)
    
(2,651
)
    
(4,924
)
    
(3,857
)
    
(7,801
)
    
(5,116
)
Net cash provided by (used in) operating activities
    
(130
)
    
5,950
      
8,017
      
7,269
      
16,112
      
8,329
  
Cash flows from investing activities
                                                
Acquisition of fixed assets
    
(6,747
)
    
(39,012
)
    
(22,274
)
    
(64,665
)
    
(83,682
)
    
(23,142
)
VAT associated with the acquisition
    
2,225
      
-
      
-
      
-
      
-
      
-
  
Repayment of loan by an equity accounted investee
    
149
      
1,400
      
149
      
1,400
      
1,400
      
155
  
Loan to an equity accounted investee
    
-
      
(131
)
    
-
      
(244
)
    
(335
)
    
-
  
Advances on account of investments
    
-
      
(8
)
    
-
      
(8
)
    
-
      
-
  
Settlement of derivatives contract
    
-
      
-
      
(528
)
    
(252
)
    
(976
)
    
(549
)
Proceeds (investment) in restricted cash, net
    
(9,344
)
    
(639
)
    
(8,241
)
    
(185
)
    
(5,990
)
    
(8,562
)
Proceeds (investment) in short term deposit
    
27,645
      
-
      
27,645
      
8,533
      
(18,599
)
    
28,722
  
Proceeds from marketable securities
    
-
      
-
      
-
      
1,785
      
(112
)
    
-
  
Net cash provided by (used in) investing activities
    
13,928
      
(38,390
)
    
(3,249
)
    
(53,636
)
    
(108,294
)
    
(3,376
)
Cash flows from financing activities
                                                
Sale of shares in subsidiaries to non-controlling interests
    
-
      
-
      
-
      
1,400
      
1,400
      
-
  
Proceeds from options
    
-
      
-
      
-
      
22
      
49
      
-
  
Cost associated with long term loans
    
(498
)
    
-
      
(8,958
)
    
(197
)
    
(2,796
)
    
(9,307
)
Payment of principal of lease liabilities
    
(205
)
    
-
      
(4,000
)
    
-
      
(4,803
)
    
(4,156
)
Proceeds from long term loans
    
(331
)
    
5,415
      
196,189
      
32,476
      
32,947
      
203,835
  
Repayment of long-term loans
    
(21,723
)
    
(2,933
)
    
(143,095
)
    
(3,390
)
    
(18,905
)
    
(148,672
)
Repayment of Debentures
    
(19,764
)
    
(8,853
)
    
(19,764
)
    
(30,730
)
    
(30,730
)
    
(20,534
)
Repayment of SWAP instrument associated with long term loans
    
-
      
-
      
(3,290
)
    
-
      
-
      
(3,418
)
Proceeds from issue of convertible debentures
    
-
      
-
      
-
      
15,571
      
15,571
      
-
  
Proceeds from issuance of Debentures, net
    
-
      
-
      
-
      
25,465
      
57,717
      
-
  
Issuance / exercise of warrants
    
-
      
-
      
-
      
3,675
      
3,746
      
-
  
Net cash provided by (used in) financing activities
    
(42,521
)
    
(6,371
)
    
17,082
      
44,292
      
54,196
      
17,748
  
                                                 
Effect of exchange rate fluctuations on cash and cash equivalents
    
(2,307
)
    
1,050
      
(3,128
)
    
2,489
      
12,370
      
(3,250
)
Increase (decrease) in cash and cash equivalents
    
(31,030
)
    
(37,761
)
    
18,722
      
414
      
(25,616
)
    
19,451
  
Cash and cash equivalents at the beginning of the period
    
90,981
      
105,020
      
41,229
      
66,845
      
66,845
      
42,836
  
Cash and cash equivalents at the end of the period
    
59,951
      
67,259
      
59,951
      
67,259
      
41,229
      
62,287
  

* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039)

Ellomay Capital Ltd. and its Subsidiaries
Operating Segments

   
PV
                      
Total
              
               
Ellomay
                
Bio
                
reportable
          
Total
  
   
Italy
    
Spain
    
Solar1
    
Talasol
    
Israel2
    
Gas
    
Dorad
    
Manara
    
segments
    
Reconciliations
    
consolidated
  
   
For the six months ended June 30, 2022
  
   
€ in thousands
  
                                                                   
Revenues
    
-
      
2,081
      
327
      
20,402
      
2,246
      
5,830
      
26,756
      
-
      
57,642
      
(28,446
)
    
29,196
  
Operating expenses
    
-
      
(100
)
    
(191
)
    
(7,088
)
    
(214
)
    
(5,539
)
    
(20,769
)
    
-
      
(33,901
)
    
20,769
      
(13,132
)
Depreciation expenses
    
-
      
(452
)
    
-
      
(5,655
)
    
(1,268
)
    
(1,607
)
    
(3,240
)
    
-
      
(12,222
)
    
4,244
      
(7,978
)
Gross profit (loss)
    
-
      
1,529
      
136
      
7,659
      
764
      
(1,316
)
    
2,747
      
-
      
11,519
      
(3,433
)
    
8,086
  
Project development costs
                                                                                    
(1,554
)
General and
                                                                                        
 administrative expenses
                                                                                    
(3,297
)
Share of loss of equity
                                                                                        
accounted investee
                                                                                    
(602
)
Operating profit
                                                                                    
2,633
  
Financing income
                                                                                    
4,439
  
Financing expenses in connection with derivatives and warrants, net
                                                                                    
338
  
Financing expenses in connection with projects finance
                                                                                    
(3,889
 )
Financing expenses in connection with debentures
                                                                                    
(1,343
 )
Interest expenses on minority shareholder loan
                                                                                    
(892
 )
Other financing expenses
                                                                                    
(834
 )
Financing expenses, net
                                                                                    
(2,181
)
Income before taxes on Income
                                                                                    
452
  
Segment assets as at June 30, 2022
    
7,273
      
15,376
      
21,684
      
267,090
      
36,404
      
31,661
      
108,718
      
120,906
      
609,112
      
(34,776
)
    
574,336
  

1  Ellomay Solar S.L, the owner of a 28 MW photovoltaic facility near the Talasol PV Plant.
2  The Talmei Yosef PV Plant located in Israel is presented under the fixed asset model and not under the financial asset model as per IFRIC 12.

Ellomay Capital Ltd. and its Subsidiaries
Reconciliation of Profit (Loss) to EBITDA

   
For the three months
ended June 30,
    
For the six months
ended June 30,
    
For the year ended December 31,
    
For the six months ended June 30,
  
   
2022
    
2021
    
2022
    
2021
    
2021
    
2022
  
   
Unaudited
  
   
€ in thousands
    
Convenience Translation into US$ in thousands*
  
Net profit (loss) for the period
    
2,771
      
(2,496
)
    
(635
)
    
(5,162
)
    
(19,640
)
    
(660
)
Financing (income) expenses, net
    
(765
)
    
3,372
      
2,181
      
6,138
      
26,884
      
2,267
  
Taxes on income (Tax benefit)
    
808
      
625
      
1,087
      
306
      
(2,281
)
    
1,129
  
Depreciation
    
3,964
      
4,025
      
7,978
      
7,076
      
15,116
      
8,289
  
EBITDA
    
6,778
      
5,526
      
10,611
      
8,358
      
20,079
      
11,025
  

* Convenience translation into US$ (exchange rate as at June 30, 2022: euro 1 = US$ 1.039)


Ellomay Capital Ltd.
Information for the Company’s Debenture Holders

Pursuant to the Deeds of Trust governing the Company’s Series C and Series D Debentures (together, the “Debentures”), the Company is required to maintain certain financial covenants. For more information, see Item 5.B of the Company’s Annual Report on Form 20-F submitted to the Securities and Exchange Commission on March 31, 2022, and below.
 
Net Financial Debt

As of June 30, 2022, the Company’s Net Financial Debt, (as such term is defined in the Deeds of Trust of the Company’s Debentures), was approximately €53.8 million (consisting of approximately €269.83 million of short-term and long-term debt from banks and other interest bearing financial obligations, approximately €115.54 million in connection with the Series C Debentures issuances (in July 2019, October 2020, February 2021 and October 2021) and Series D Debentures issuance (in February 2021), net of approximately €61.7 million of cash and cash equivalents, short-term deposits and marketable securities and net of approximately €269.85 million of project finance and related hedging transactions of the Company’s subsidiaries).

3 Short-term and long-term debt from banks and other interest-bearing financial obligations amount provided above, includes an amount of approximately €3.8 million costs associated with such debt, which was capitalized and therefore offset from the debt amount that is recorded in the Company’s balance sheet.
 
4 Debentures amount provided above includes an amount of approximately €1.7 million associated costs, which was capitalized and therefore offset from the debentures amount that is recorded in the Company’s balance sheet.
 
5 The project finance amount deducted from the calculation of Net Financial Debt includes project finance obtained from various sources, including financing entities and the minority shareholders in project companies held by the Company (provided in the form of shareholders’ loans to the project companies).

Information for the Company’s Series C Debenture Holders.
 
The Deed of Trust governing the Company’s Series C Debentures (as amended on June 6, 2022, the “Series C Deed of Trust”), includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for two consecutive quarters is a cause for immediate repayment. As of June 30, 2022, the Company was in compliance with the financial covenants set forth in the Series C Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series C Deed of Trust) was approximately €130.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 29.3%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA6, was 2.1.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series C Deed of Trust) for the four-quarter period ended June 30, 2022:

   
For the four-quarter period ended June 30, 2022
  
   
Unaudited
  
   
€ in thousands
  
Loss for the period
    
(15,098
)
Financing expenses, net
    
22,927
  
Taxes on income
    
(1,495
)
Depreciation
    
15,998
  
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
    
3,389
  
Share-based payments
    
110
  
Adjusted EBITDA as defined the Series C Deed of Trust
    
25,831
  


6 The term “Adjusted EBITDA” is defined in the Series C Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments. The Series C Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series C Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”

Information for the Company’s Series D Debenture Holders

The Deed of Trust governing the Company’s Series D Debentures includes an undertaking by the Company to maintain certain financial covenants, whereby a breach of such financial covenants for the periods set forth in the Series D Deed of Trust is a cause for immediate repayment. As of June 30, 2022, the Company was in compliance with the financial covenants set forth in the Series D Deed of Trust as follows: (i) the Company’s Adjusted Shareholders’ Equity (as defined in the Series D Deed of Trust) was approximately €130.1 million, (ii) the ratio of the Company’s Net Financial Debt (as set forth above) to the Company’s CAP, Net (defined as the Company’s Adjusted Shareholders’ Equity plus the Net Financial Debt) was 29.3%, and (iii) the ratio of the Company’s Net Financial Debt to the Company’s Adjusted EBITDA7 was 2.1.

The following is a reconciliation between the Company’s loss and the Adjusted EBITDA (as defined in the Series D Deed of Trust) for the four-quarter period ended June 30, 2022:

   
For the four-quarter period ended June 30, 2022
  
   
Unaudited
  
   
€ in thousands
  
Loss for the period
    
(15,098
)
Financing expenses, net
    
22,927
  
Taxes on income
    
(1,495
)
Depreciation
    
15,998
  
Adjustment to revenues of the Talmei Yosef PV Plant due to calculation based on the fixed asset model
    
3,389
  
Share-based payments
    
110
  
Adjusted EBITDA as defined the Series D Deed of Trust
    
25,831
  

7 The term “Adjusted EBITDA” is defined in the Series D Deed of Trust as earnings before financial expenses, net, taxes, depreciation and amortization, where the revenues from the Company’s operations, such as the Talmei Yosef PV Plant, are calculated based on the fixed asset model and not based on the financial asset model (IFRIC 12), and before share-based payments, when the data of assets or projects whose Commercial Operation Date (as such term is defined in the Series D Deed of Trust) occurred in the four quarters that preceded the relevant date will be calculated based on Annual Gross Up (as such term is defined in the Series D Deed of Trust). The Series D Deed of Trust provides that for purposes of the financial covenant, the Adjusted EBITDA will be calculated based on the four preceding quarters, in the aggregate. The Adjusted EBITDA is presented in this press release as part of the Company’s undertakings towards the holders of its Series D Debentures. For a general discussion of the use of non-IFRS measures, such as EBITDA and Adjusted EBITDA see above under “Use of NON-IFRS Financial Measures.”